Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Kanvas Biosciences
237 Tower Road, McGovern Center
Ithaca, NY 14853
Phone: 617-435-4900
https://www.kanvasbio.com/

Kanvas Biosciences is building the world's first microbiome drug screening and drug discovery platform to accelerate live biotherapeutic product (LBP) development. Leveraging its unparalleled ability to spatially map the microbiome and profile host-gene expression at single-cell resolution, the company is constructing the most comprehensive and robust microbiome data resource for future drug development. Kanvas Biosciences' technology was initially developed at Cornell University and exclusively licensed.

Key Contact
Name
Hao Shi
Title
Co-Founder & CEO
Funding Events

Date
Amount
Type
Investors
Valuation
06/22/23 $12,000,000 Pre-Series A Cooke LLC
DCVC
Lions Capital
Triple Impact Capital
Uncommon Denominator
undisclosed
07/01/24 $12,500,000 DCVC
FemHealth Ventures
Germin8 Ventures
Ki Tua Fund
Lions Capital
Pangaea Ventures
undisclosed